Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Unique lipid cargoes in APOE4 human brain-derived extracellular vesicles recruit cell adhesion molecules and promote tauopathy in Alzheimer’s disease
Ikezu, Tsuneya , Zhang, Zhengrong , Bao, Hanmei , Ikezu, Tadafumi C. , Melvin, Bridgette, Scholes, Clara, You, Yang , Ellison, Justice, Kanekiyo, Takahisa , DeTure, Michael , Peng, Junmin , Ikezu, Seiko , Yu, Kaiwen , Ikezu, Tadafumi, Ravula, Arun Reddy, Yang, You , Kanekiyo, Takahisa , Wszolek, Z.K. , Han, Xianlin , Peng, Junmin , Ikezu, Tsuneya , Ravula, Arun Reddy , Ellison, Justice, Wszołek, Zbigniew K. , Dickson, Dennis W.

No container title available | May 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6508552/v1 | PMID 40502793 Get It

Abstract Brain-derived extracellular vesicles (BDEVs) carry tau filaments and promote tau transmission in Alzheimer’s disease (AD). However, how APOE ε4 allele, a key genetic risk factor for AD, may change BDEV molecular structures thereby facilitate disease progression is poorly understood. Here we report comprehensive analyses of BDEVs isolated from human E3/3 and E4/4 AD brains with a biological multi-omics approach. E4/4 BDEVs significantly enhanced tau propagation in aged human MAPT (Tau) knock-in and APPNL-G-F: Tau double knock-in mouse brains in vivo and increased neuronal uptake and excitability in induced pluripotent stem cell-derived neurons (iNeurons) compared to E3/3 BDEVs in vitro. Notably, correlation analysis of BDEV-lipidome and proteome exhibited synergistic enrichment in unsaturated free fatty acid (FFA)18:2, a precursor of inflammatory w6 FFA, and neural cell adhesion molecule 1 (NCAM1). Treatment of iNeurons with FFA 18:2 induces NCAM1 expression, recruits tau into EVs and enhance their tau seeding activity, which is blocked by NCAM1 antibody in vitro . Finally, intracerebroventricular injection of NCAM1 antibody significantly alleviated pathological tau accumulation and glial inflammation in PS19 tauopathy mouse brains, which had previously been reported to exhibit increased level of 18:2 FFA. This highlights novel pathological mechanism in tau transfer mediated by E4/4 BDEVs and emphasizes strong therapeutic potential of targeting EV molecules in AD progression.
Measles immunity gaps: distinct serological profiles from the United States and India
Ovsyannikova, Inna G. , Poland, Gregory A., Quach, Huy Quang , Kennedy, Richard B. , Poland, Gregory A.

Journal of Travel Medicine | May 26, 2025 | Volume: 32 | Issue: 5 | Pages: No page available

10.1093/jtm/taaf043 | PMID 40415187 Get It

Sustained measles elimination requires high herd immunity, maintained through vaccination and verified by global serosurveillance. Comparing measles neutralizing antibody titres in US and Indian populations, we identified distinct age-specific and country-specific trends. These findings highlight the urgent need for tailored strategies to strengthen population immunity and global measles control efforts.
Prognostic impact of cardiac resynchronization therapy in wild-type transthyretin amyloid cardiomyopathy
Siontis, Konstantinos C. , Tan, Nicholas Y. , Maanja, Maren , Chahal, Choudhary A., Hodge, David O. , Lin, Grace , Sehrawat, Ojasav , Hodge, David, Miller, Wayne L. , Dispenzieri, Angela , Chahal, Choudhary A., Dispenzieri, Angela , Noseworthy, Peter A.

Amyloid | May 26, 2025 | Volume: 32 | Issue: 3 | Pages: 289-291

10.1080/13506129.2025.2504443 | PMID 40415407 Get It

Outcomes of an extended combined phaco-kahook dual blade procedure in glaucoma patients
Magacho, Leopoldo , Franco, Cláudia Gomide Vilela de Sousa , Akio, Eduardo , Pereira, Ana Cláudia Alves, Teno, Bruno, Lucena-Neto, Francisco, Faria, Bruno M. , Vieira, Júlia Maggi , Vianello, Marcos Pereira , Kanadani, Fábio Nishimura , Kanadani, Fábio N.

European Journal of Ophthalmology | May 26, 2025 | Volume: 35 | Issue: 6 | Pages: 2122-2129

10.1177/11206721251344400 | PMID 40415406 Get It

Purpose To compare the outcomes of standard combined Phaco-Kahook Dual Blade (KDB) surgery (GI) with those of the extended technique (GII). Methods This retrospective, comparative, multicenter, case-control study enrolled patients with one-year follow-up. GI removed 90° of the trabecular meshwork (TM) extension during KDB, whereas GII removed 150°. The successful criteria were based on a modification of the AAO PPP recommendations - Reporting Clinical Endpoints in Studies of Minimally Invasive Glaucoma Surgery. Qualified success was achieved with or without medication, while absolute success was achieved without the use of any ocular hypotensive medication. Results A total of 72 eyes (36 in both groups) were included. The IOP was similar between groups preoperatively (GI: 17.0 ± 2.7 mmHg vs. GII: 17.5 ± 4.2 mmHg, p = 0.5), and at 12 months postoperatively (GI: 13.5 ± 2.8 mmHg vs. GII: 12.3 ± 2.7 mmHg, p = 0.06). The number of glaucoma medications was reduced from 1.7 ± 0.9 to 0.4 ± 0.8 in GI ( p < 0.001) and from 2.1 ± 0.8 to 0.4 ± 0.7 in GII ( p < 0.001). At 12 months, both groups reduced comparable glaucoma medications ( p = 0.9). Qualified success was achieved in 77.1% of the eyes with GI and 94.4% with GII ( p = 0.03), whereas complete success was achieved in 68.6% of the eyes with GI and 69.4% with GII ( p = 0.7). No serious complications were observed in any of the groups. Conclusion Extended combined Phaco-KDB surgery showed greater relative success than the Standard Phaco-KDB technique. Both techniques achieved similar IOP reduction at 12 months postoperatively.
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group
Indelicato, Daniel J. , Callan, Alexandra K. , Krailo, Mark , DelRocco, Natalie , Buxton, Allen, Binitie, Odion , Christ, Alexander B. , Kessell, Sandy, Chuba, Paul J. , Nadel, Helen , Pawel, Bruce , DuBois, Steven G. , Janeway, Katherine A. , Leavey, Patrick J. , Mascarenhas, Leo , Ahmed, Safia K. , Binitie, Odion , Christ, Alexander B , DuBois, Steven G , Janeway, Katherine A , Leavey, Patrick , Mascarenhas, Leo , Laack, Nadia N Issa , Indelicato, Daniel J , Nadel, Helen , Görlick, Richard , Reed, Damon R. , Laack, Nadia N.

Pediatric Blood & Cancer | May 26, 2025 | Volume: 72 | Issue: 8 | Pages: No page available

10.1002/pbc.31820 | PMID 40415235 Get It

AbstractPatients with resectable Ewing sarcoma (ES) in select sites, such as the pelvis or chest wall, have a higher risk of positive microscopic margins following surgery. AEWS1031 was the first North American/Australasia ES cooperative group trial allowing standardized preoperative radiotherapy, intended to minimize the morbidity of combined modality local tumor control as well as improve the likelihood of clear surgical margins. In this study, we found that the use of low‐dose preoperative radiation to a smaller target volume resulted in a high rate of R0 resection. The robust pathologic response rate strengthens existing evidence illustrating the radiosensitivity of Ewing sarcoma.
Phase Determination and Demonstration of Parental Mosaicism of Intragenic PRKN Deletions Initially Identified by Chromosomal Microarray Analysis
Choate, Lauren A. , Hoffman, Francis, Newman, Jessica , Runke, Cassandra , Webley, Matthew, Hoppman, Nicole L., Thorland, Erik C., Newman, Jessica H, Hoffman, Francis, Newman, Jessica H.

Genes | May 25, 2025 | Volume: 16 | Issue: 6 | Pages: 630

10.3390/genes16060630 | PMID 40565523 Get It

Background: Autosomal recessive juvenile Parkinson disease (ARJP) is an early-onset neurodegenerative disorder characterized by Parkinsonian motor symptoms with slow progression and preserved cognition. Biallelic pathogenic variants within the PRKN gene are associated with ARJP. Among PRKN pathogenic variants, deletions are a frequent occurrence and may be identified through chromosomal microarray testing. Methods: Here we present a case with two intragenic PRKN deletions initially identified as a secondary finding using chromosomal microarray. One deletion was paternally inherited and the second initially appeared to be de novo. In addition to microarray which initially identified the two deletions, long-range GAP-PCR and Sanger sequencing were used to further characterize the de novo deletion and phase of the deletions. Results: Molecular characterization of the apparently de novo deletion demonstrated low-level maternal mosaicism of this deletion, thus proving that these deletions are in trans in the proband, yielding a diagnosis of autosomal recessive juvenile Parkinson disease. Conclusions: This case highlights the utility of a diagnostic approach combining microarray, long-range PCR, and Sanger sequencing to establish the phase and confirm biallelic PRKN deletions in a patient with ARJP. Furthermore, these findings highlight the importance of investigating the possibility of parental mosaicism to determine the phase of autosomal recessive variants and establish accurate recurrence risks.
AI-Based Predictive Models for Cardiogenic Shock in STEMI: Real-World Data for Early Risk Assessment and Prognostic Insights
Stamate, Elena , Culea-Florescu, Anisia-Luiza , Miron, Mihaela , Piraianu, Alin Ionut , Dumitrascu, Adrian , Fulga, Ana , Patrascanu, Octavian Stefan , Iancu, Doriana , Ciobotaru, Octavian Cătălin , Ciobotaru, Oana Roxana , Dumitrascu, Adrian George , Patrascanu, Octavian Stefan , Ciobotaru, Octavian Catalin , Ciobotaru, Oana Roxana , Fulga, Iuliu

Journal of Clinical Medicine | May 25, 2025 | Volume: 14 | Issue: 11 | Pages: 3698

10.3390/jcm14113698 | PMID 40507459 Get It

Background: Cardiogenic shock (CS) is a life-threatening complication of ST-elevation myocardial infarction (STEMI) and remains the leading cause of in-hospital mortality, with rates ranging from 5 to 10% despite advances in reperfusion strategies. Early identification and timely intervention are critical for improving outcomes. This study investigates the utility of machine learning (ML) models for predicting the risk of CS during the early phases of care—prehospital, emergency department (ED), and cardiology-on-call—with a focus on accurate triage and prioritization for urgent angiography. Results: In the prehospital phase, the Extra Trees classifier demonstrated the highest overall performance. It achieved an accuracy (ACC) of 0.9062, precision of 0.9078, recall of 0.9062, F1-score of 0.9061, and Matthews correlation coefficient (MCC) of 0.8140, indicating both high predictive power and strong generalization. In the ED phase, the support vector machine model outperformed others with an ACC of 78.12%. During the cardiology-on-call phase, Random Forest showed the best performance with an ACC of 81.25% and consistent values across other metrics. Quadratic discriminant analysis showed consistent and generalizable performance across all early care stages. Key predictive features included the Killip class, ECG rhythm, creatinine, potassium, and markers of renal dysfunction—parameters readily available in routine emergency settings. The greatest clinical utility was observed in prehospital and ED phases, where ML models could support the early identification of critically ill patients and could prioritize coronary catheterization, especially important for centers with limited capacity for angiography. Conclusions: Machine learning-based predictive models offer a valuable tool for early risk stratification in STEMI patients at risk for cardiogenic shock. These findings support the implementation of ML-driven tools in early STEMI care pathways, potentially improving survival through faster and more accurate decision-making, especially in time-sensitive clinical environments.
Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7
Al‐Shaikh, Rana Hanna , Jansen‐West, Karen , Strongosky, Audrey , Parrales, Zoe, Dunmore, Judith A. , Song, Yuping , Guevara, Juan , Teive, Hélio Afonso Ghizoni , Dulski, Jarosław , Petrucelli, Leonard , Wszołek, Zbigniew K. , Prudencio, Mercedes , Wszolek, Z.K. , Hanna Al-Shaikh, Rana , Teive, Helio A , Prudencio, Mercedes , Dunmore, Judith A , Dulski, Jaroslaw , Gendron, Tania F. , Guevara, Juan C., Sławek, Jarosław

International Journal of Molecular Sciences | May 25, 2025 | Volume: 26 | Issue: 11 | Pages: 5070

10.3390/ijms26115070 | PMID 40507882 Get It

Spinocerebellar ataxia type 7 (SCA7), a rare form of ataxia, possesses a wide phenotypic spectrum ranging from classic ataxic symptoms to blindness, multiorgan failure, cardiomyopathy, and early death among younger age groups. Biomarkers associated with disease progression and severity could aid in disease prognostication. We evaluated the utility of glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) in distinguishing patients with SCA7 from healthy controls and estimating patient prognosis. GFAP and NfL levels were measured in 23 plasma and 20 cerebrospinal fluid (CSF) samples from asymptomatic (N = 3) and symptomatic SCA7 participants (N = 10) and from healthy controls (N = 8). GFAP concentrations were elevated in the plasma (82.7 pg/mL) and CSF (9318 pg/mL) of patients with SCA7 compared to controls (plasma: 48.0 pg/mL; CSF: 89,056 pg/mL). Similarly, NfL plasma (21.6 pg/mL) and CSF (2615.0 pg/mL) levels were also significantly upregulated in SCA7 compared to controls (plasma: 8.2 pg/mL; CSF: 414.6 pg/mL). Higher levels of NfL, but not of GFAP, significantly discriminated symptomatic SCA7 patients from controls (area under de curve, AUC: 0.898, p = 0.0059, in plasma, and AUC: 1.0, p = 0.0012, in CSF). The levels of both biomarkers increased overtime, with plasma NfL levels strongly associated with a worse score in the scale for the assessment and rating of ataxia (SARA) (Spearman r: 0.8354, p = 0.0007; regression analysis: β: 0.021, 95% CI: 0.008–0.035, p = 0.0048). These findings suggest that NfL could serve as a valuable biomarker for monitoring disease progression and prognosis in SCA7 patients.
Assisted reproductive technology utilization for cancer survivors: how we can do better
Hupy, Erin , Khan, Zaraq , Ainsworth, Alessandra J. , Shenoy, Chandra C. , Cope, Adela G. , Hupy, Erin

JNCI: Journal of the National Cancer Institute | May 25, 2025 | Volume: 117 | Issue: 7 | Pages: 1299-1301

10.1093/jnci/djaf101 | PMID 40413723 Get It

Alternating 2D and 3D Culture Reduces Cell Size and Extends the Lifespan of Placenta-Derived MSCs
Pan, Ying , Li, Han , Yang, Yakun , Wang, Aijun , Zhu, Wuqiang , Wang, Shue , Wang, Aijun , Wang, Shue , Zhu, Wuqiang , Wu, Xinran , Xie, Liangqi , Lei, Yuguo

No container title available | May 25, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.20.655182 | PMID 40475514 Get It

Abstract Mesenchymal stem cells (MSCs) offer significant therapeutic potential, but traditional 2D culture on rigid substrates results in progressive cell enlargement and senescence, reducing proliferative capacity and therapeutic potency. This poses a major challenge for widespread clinical application. We explored a novel strategy for placenta-derived MSCs combining 2D expansion with 3D spheroid culture to address these limitations. Our research shows that culturing MSCs as 3D spheroids significantly reduces individual cell size and size distribution compared to 2D culture. Spheroid formation is feasible in chemically defined media with minimal cell death, and is enhanced by extracellular matrix protein supplementation. Although MSCs do not proliferate in 3D suspension, an alternating 2D/3D culture protocol, transitioning cells between 2D flasks and 3D spheroids after each passage, effectively slows MSC enlargement and senescence over long periods. This alternating method also preserves MSC immunomodulatory function, unlike continuous 2D culture which leads to its loss. For scalability, we developed an RGD-functionalized alginate hydrogel tube (AlgTube) system that mimics this alternating environment, supporting both adherent growth and chemically triggered spheroid formation. This alternating 2D/3D culture strategy and the scalable AlgTube platform provide a foundation for developing next-generation MSC manufacturing technologies to meet future clinical demands.